MedTrace Logo

Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss

NCT07280403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-18

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the effect of a low carbohydrate higher protein diet, modelled after the Atkins program on weight loss, glycemic control, risk markers of cardiovascular disease and body composition in patients taking semaglutide.

Participants will:

* Be randomized to follow either a low carb, higher protein diet or a low fat diet for 3 months.
* Visit the clinic at week 2, 4, 8 and 12 to meet with a dietician, fill out a symptoms questionnaire and for bloodwork
* Complete 3-day food records 4 times over the 12 weeks.

Conditions

Interventions

BEHAVIORAL

Low Carbohydrate

Low carbohydrate diet

BEHAVIORAL

Low Fat

Low fat diet

Sponsors & Collaborators

  • Simply Good Foods USA, Ltd.

    collaborator UNKNOWN

  • INQUIS Clinical Research

    lead INDUSTRY

Principal Investigators

  • Janice Campbell · INQUIS Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-12
Primary Completion
2025-10-14
Completion
2025-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07280403 on ClinicalTrials.gov